Molecular Partners AG (MOLN) — Cash Flow-to-Debt Ratio
Molecular Partners AG (MOLN) has a Cash Flow-to-Debt Ratio of -0.57x as of September 2025, meaning its operating cash flow of CHF-9.49 Million could theoretically repay -1% of its total liabilities (CHF16.62 Million) in one year. Check Molecular Partners AG total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Molecular Partners AG Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for Molecular Partners AG across 12 annual periods. Also explore MOLN total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Molecular Partners AG (2013–2024)
Year-by-year debt coverage analysis for Molecular Partners AG. For market capitalisation and broader financial context, see Molecular Partners AG market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CHF) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -3.51x | CHF-59.25 Million | CHF16.89 Million | ▼ -30.3% |
| 2023 | -2.69x | CHF-59.01 Million | CHF21.92 Million | ▼ -161.5% |
| 2022 | 4.38x | CHF118.57 Million | CHF27.09 Million | ▲ +414.6% |
| 2021 | -1.39x | CHF-90.95 Million | CHF65.38 Million | ▼ -285.6% |
| 2020 | -0.36x | CHF-28.98 Million | CHF80.33 Million | ▼ -1441.5% |
| 2019 | -0.02x | CHF-1.19 Million | CHF50.80 Million | ▲ +96.5% |
| 2018 | -0.67x | CHF-42.47 Million | CHF63.45 Million | ▲ +53.7% |
| 2017 | -1.45x | CHF-40.02 Million | CHF27.69 Million | ▼ -97.3% |
| 2016 | -0.73x | CHF-35.38 Million | CHF48.30 Million | ▼ -286.9% |
| 2015 | 0.39x | CHF26.50 Million | CHF67.60 Million | ▲ +257.5% |
| 2014 | -0.25x | CHF-11.33 Million | CHF45.54 Million | ▼ -13.0% |
| 2013 | -0.22x | CHF-13.61 Million | CHF61.80 Million | — |